HapMap3 cohort

Aliases

CEU founder population, HapMap, HapMap 3, HapMap Phase 3, HapMap SNP, HapMap3

Related entities (22)

Mentioned in (53)

Papers in which this entity is mentioned.

• Specificity, length and luck drive gene rankings in association studies. (2026)
• MUSSEL: Enhanced Bayesian polygenic risk prediction leveraging information across multiple ancestry groups. (2024)
• Yield of genetic association signals from genomes, exomes and imputation in the UK Biobank. (2024)
• Multiomic prioritisation of risk genes for anorexia nervosa. (2023)
• Pervasive Downward Bias in Estimates of Liability-Scale Heritability in Genome-wide Association Study Meta-analysis: A Simple Solution. (2023)
• Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. (2023)
• Polygenic prediction across populations is influenced by ancestry, genetic architecture, and methodology. (2023)
• Genetic architecture of 11 major psychiatric disorders at biobehavioral, functional genomic and molecular genetic levels of analysis. (2022)
• Cross-tissue transcriptome-wide association studies identify susceptibility genes shared between schizophrenia and inflammatory bowel disease. (2022)
• Genetic variants associated with longitudinal changes in brain structure across the lifespan. (2022)
• Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
• Polygenic prediction via Bayesian regression and continuous shrinkage priors. (2019)
• Sex differences in the genetic architecture of obsessive-compulsive disorder. (2019)
• Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. (2019)
• Genomic structural equation modelling provides insights into the multivariate genetic architecture of complex traits. (2019)
• Identification of common genetic risk variants for autism spectrum disorder. (2019)
• Genome-wide association meta-analysis in 269,867 individuals identifies new genetic and functional links to intelligence. (2018)
• Eigenanalysis of SNP data with an identity by descent interpretation. (2016)
• KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. (2016)
• Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors. (2016)
• High-Accuracy HLA Type Inference from Whole-Genome Sequencing Data Using Population Reference Graphs. (2016)
• Genome-wide association study identifies 74 loci associated with educational attainment. (2016)
• DNA methylation signature of human fetal alcohol spectrum disorder. (2016)
• An introductory review of parallel independent component analysis (p-ICA) and a guide to applying p-ICA to genetic data and imaging phenotypes to identify disease-associated biological pathways and systems in common complex disorders. (2015)
• Genome-Wide Meta-Analysis of Longitudinal Alcohol Consumption Across Youth and Early Adulthood. (2015)
• HLAreporter: a tool for HLA typing from next generation sequencing data. (2015)
• Reconstructing A/B compartments as revealed by Hi-C using long-range correlations in epigenetic data. (2015)
• Hidden Markov Model-Based CNV Detection Algorithms for Illumina Genotyping Microarrays. (2014)
• The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. (2014)
• Heritability and genomics of gene expression in peripheral blood. (2014)
• A mega-analysis of genome-wide association studies for major depressive disorder. (2013)
• Large-scale genotyping identifies 41 new loci associated with breast cancer risk. (2013)
• HLA typing from 1000 genomes whole genome and whole exome illumina data. (2013)
• A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. (2013)
• Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women. (2012)
• Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction. (2011)
• A framework for variation discovery and genotyping using next-generation DNA sequencing data. (2011)
• Gene set analysis of genome-wide association studies: methodological issues and perspectives. (2011)
• Haplotype block structure of the genomic region of the mu opioid receptor gene. (2011)
• Expanding the range of ZNF804A variants conferring risk of psychosis. (2011)
• Genome-wide association study identifies five new schizophrenia loci. (2011)
• Integrative analysis of the melanoma transcriptome. (2010)
• The psychiatric GWAS consortium: big science comes to psychiatry. (2010)
• Multiple cholinergic nicotinic receptor genes affect nicotine dependence risk in African and European Americans. (2010)
• Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. (2010)
• The psychiatric GWAS consortium: big science comes to psychiatry. (2010)
• Tackling the widespread and critical impact of batch effects in high-throughput data. (2010)
• The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. (2009)
• Genomewide association studies: history, rationale, and prospects for psychiatric disorders. (2009)
• Genomewide association studies and human disease. (2009)
• Genome-wide and candidate gene association study of cigarette smoking behaviors. (2009)
• PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. (2007)
• Accurate and reliable high-throughput detection of copy number variation in the human genome. (2006)

Merged raw entities (12)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.